These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 619476)

  • 1. Medical adrenalectomy and plasma steroids in advanced breast carcinoma.
    Newsome HH; Brown PW; Terz JJ; Lawrence W
    Surgery; 1978 Jan; 83(1):83-9. PubMed ID: 619476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels.
    Samojlik E; Santen RJ; Wells SA
    J Clin Endocrinol Metab; 1977 Sep; 45(3):480-7. PubMed ID: 903399
    [No Abstract]   [Full Text] [Related]  

  • 3. How effective is surgical adrenalectomy in lowering steroid hormone concentrations?
    Worgul TJ; Santen RJ; Samojlik E; Wells SA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):22-6. PubMed ID: 6459336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
    Santen RJ; Samojlik E; Lipton A; Harvey H; Ruby EB; Wells SA; Kendall J
    Cancer; 1977 Jun; 39(6 Suppl):2948-58. PubMed ID: 194681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical and surgical adrenalectomy in patients with advanced breast carcinoma.
    Newsome HH; Brown PW; Terz JJ; Lawrence W
    Cancer; 1977 Feb; 39(2):542-6. PubMed ID: 837338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
    Samojlik E; Veldhuis JD; Wells SA; Santen RJ
    J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglutethimide in the treatment of advanced breast cancer.
    Stuart-Harris RC; Smith IE
    Cancer Treat Rev; 1984 Sep; 11(3):189-204. PubMed ID: 6241038
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer.
    van Veelen H; Willemse PH; Sleijfer DT; Sluiter WJ; Doorenbos H
    Cancer Treat Rep; 1985 Sep; 69(9):977-83. PubMed ID: 3161613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.
    Harris AL; Dowsett M; Cantwell BM; Sainsbury JR; Needham G; Farndon J; Wilson R
    Breast Cancer Res Treat; 1986; 7 Suppl():S69-72. PubMed ID: 2943338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
    Samojlik E; Santen RJ; Kirschner MA; Ertel NH
    Cancer Res; 1982 Aug; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.
    Wells SA; Santen RJ; Lipton A; Haagensen DE; Ruby EJ; Harvey H; Dilley WG
    Ann Surg; 1978 May; 187(5):475-84. PubMed ID: 646874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer.
    Lipton A; Santen RJ
    Cancer; 1974 Feb; 33(2):503-12. PubMed ID: 4812767
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of dexamethasone on the peripheral plasma concentrations of androstenedione, testosterone and cortisol in the pregnant rhesus monkey.
    Challis JR; Davies IJ; Benirschke K; Hendrickx AG; Ryan KJ
    Endocrinology; 1975 Jan; 96(1):185-92. PubMed ID: 1109902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.
    Bruning PF; Bonfrer JM; Hart AA; van der Linden E; de Jong-Bakker M; Moolenaar AJ; Nooijen WJ
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):369-76. PubMed ID: 2702989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy.
    Dowsett M; Harris AL; Smith IE; Jeffcoate SL
    J Clin Endocrinol Metab; 1984 Jan; 58(1):99-104. PubMed ID: 6227629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism.
    Santen RJ; Lipton A; Kendall J
    JAMA; 1974 Dec 23-30; 230(12):1661-5. PubMed ID: 4373589
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
    Samojlik E; Santen RJ
    J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.
    Harris AL; Dowsett M; Jeffcoate SL; McKinna JA; Morgan M; Smith IE
    J Clin Endocrinol Metab; 1982 Oct; 55(4):718-22. PubMed ID: 6213633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency of the effect of D-stereoisomer of aminoglutethimide on adrenal and extraadrenal steroidogenesis.
    Samojlik E; Santen RJ
    J Clin Endocrinol Metab; 1980 Sep; 51(3):462-5. PubMed ID: 6447707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.